A prognostic signature based on insulin-signaling-pathway genes for hepatocellular carcinoma
In summary, we constructed a prognostic signature based on insulin signaling pathway genes. The excellent performance and applicability of our model underscores its advantages and reliability as a clinical tool. Moreover, we validated SLC2A1 was an independent prognostic factor in a HCC independent cohort.
Authors
- Hao Song (ORCID: https://orcid.org/0000-0002-2811-0370)
- Kunwei Peng (ORCID: https://orcid.org/0000-0003-4494-8154)
- Yanyan Zhang (ORCID: https://orcid.org/0000-0003-3330-4062)
- Weijie Cui (ORCID: https://orcid.org/0000-0002-4950-1514)
Institutions
- Guangdong Medical College (CN)
- Second Affiliated Hospital of Guangzhou Medical University (CN)
- First Affiliated Hospital of Guangzhou Medical University (CN)
- Guangzhou First People's Hospital (CN)
- Guangzhou Medical University (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-10-15
- DOI
- https://doi.org/10.1007/s12672-025-03763-x
- Primary Topic
- Metabolism, Diabetes, and Cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Guangzhou Municipal Science and Technology Project